NATCO PHARMA LTD.
Long

NATCOPHARMA :NSE BULLISH FLAG & TRENDLINE BO DTF/WTF

194
NATCOPHARMA STOCK Analysis

TRADE PLAN (DTF Close Price for SWING /POSITIONAL)
ENTRY - 1413 50% Qty, Add 50% qty 1482 DTF Close
SL - 1320
TARGET --01- 1482 SWING , TGT02--1624
Hold For a 6M -1 Year or TGT 2

Chart Pattern :
STOCK had a 3Month Streak to Touch an ATH of 1639, Retracing to 50% FIBO Level forming a Bullish Flag Pattern.

INDICATORS EMA :
The Price is Currently Trading near 50EMA, and 20EMa below 50EMA in DTF. STOCK EMAs are currently in Transitional stage of alignment where this week an. 8%+ price rise with reasonable Volumes indicating start of a bullish Trend on DTF/WTF.

FIBO/E :
Currently the price is above the 38.2% FIBO Retracement Level, Early Entry can be take as per your risk ability. Safe Investors Enter as above .

Volumes: After the surge in volumes in the past 3months There is a muted in Volume on the selling side of the Weekly Charts after the 4 weeks Pullback. Results a=for the Quarter are due next week.

Keep in your Priority Watch List

Disclaimer: For Education/Reference Purpose Only, Trade at your Own Risk with correct position sizing and SL based on your Risk appetite (Exit when price closes 7to8% below your Entry).and re enter when trend reverses...
Trail Your SL progressively. Learn/Know and Review the Stock trading Technical Terminology. Check Verify the Financial fundamentals of the Stock and Seek Advice from a Certified Financial Advisor prior to Investing. Prefer Entry with 25% quantity, Add in Tranches of 25%-50% as prices moves upwards recommended.

MTFA- Multiple Time Frame Analysis
DTF -Daily Time Frame
WTF-Weekly Time Frame
MTF- Monthly Time Frame
ATH-All Time High
LTH -LifeTime High
RBC&H-Rounding Bottom Cup/Handle
BO- Breakout Close
EMA -Exponential Moving Average
FIBO R/E -Trend based Fibonacci Retracement/Extension
SL Stop Loss
TBD- To be Decided
CHoCH- Change of Character Bullish/Bearish
MSB/BOS -Break Out Structure
FVG Fair Value Gap
20VMA -20Volume Moving Average
SWING/POSITIONAL Trade

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.